Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

PFIZER INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 1849-01-01

Employees: 88K

Market Cap: $163.3B

Website: http://www.pfizer.com

Clinical Trials

A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine

Phase 4

Completed

Conditions: Overactive Bladder

Interventions: Drug: Placebo
Drug: Fesoterodine 8mg
Drug: Fesoterodine 4mg

First Posted Date: 2011-02-23

Last Posted Date: 2014-03-26

Lead Sponsor: Pfizer

Target Recruit Count: 2012

Registration Number: NCT01302067

Locations: 🇺🇸
Women's Healthcare Associates dba Rosemark WomenCare Specialists, Idaho Falls, Idaho, United States
🇺🇸
Institute for Female Pelvic Medicine, Allentown, Pennsylvania, United States
🇨🇦
Can-Med Clinical Research, Victoria, British Columbia, Canada

and more 274 locations

Efficacy and Safety of AN2898 and AN2728 Topical Ointments to Treat Mild-to-Moderate Atopic Dermatitis

Phase 2

Completed

Conditions: Dermatitis, Atopic

Interventions: Drug: AN2898 ointment, 1%
Drug: AN2728 ointment, 2%
Drug: AN2898 ointment vehicle
Drug: AN2728 ointment vehicle

First Posted Date: 2011-02-23

Last Posted Date: 2019-02-22

Lead Sponsor: Pfizer

Target Recruit Count: 46

Registration Number: NCT01301508

Locations: 🇦🇺
Anacor Investigational Site, Victoria Park, Western Australia, Australia

Efficacy and Safety of AN2690 Topical Solution to Treat Onychomycosis of the Toenail

Phase 3

Completed

Conditions: Onychomycosis of Toenails

Interventions: Drug: AN2690 Topical Solution, 5%
Drug: Solution Vehicle

First Posted Date: 2011-02-23

Last Posted Date: 2019-04-03

Lead Sponsor: Pfizer

Target Recruit Count: 604

Registration Number: NCT01302119

Locations: 🇨🇦
Investigational Site, Quebec, Canada

Single-Dose And Multiple-Dose Safety And Tolerability Study Of PF-04856883 In Type 2 Diabetic Adult Females

Phase 1

Completed

Conditions: Glucose Metabolism Disorders
Diabetes Mellitus
Diabetes Mellitus, Type 2
Metabolic Diseases
Endocrine System Diseases

Interventions: Biological: PF-04856883
Biological: Placebo

First Posted Date: 2011-02-23

Last Posted Date: 2018-02-09

Lead Sponsor: Pfizer

Target Recruit Count: 84

Registration Number: NCT01301456

Locations: 🇺🇸
ICON Clinical Pharmacology, LLC, Omaha, Nebraska, United States
🇺🇸
CRI Worldwide, LLC, Philadelphia, Pennsylvania, United States
🇺🇸
Comprehensive Phase One (A Division of Comprehensive NeuroScience, Inc.), Miramar, Florida, United States

and more 4 locations

A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine.

Phase 4

Completed

Conditions: Urinary Bladder, Overactive

Interventions: Drug: Fesoterodine 8 mg
Drug: Placebo

First Posted Date: 2011-02-23

Last Posted Date: 2018-12-04

Lead Sponsor: Pfizer

Target Recruit Count: 990

Registration Number: NCT01302054

Locations: 🇺🇸
Women's Specialty Center, Jackson, Mississippi, United States
🇺🇸
CRC of Jackson, Jackson, Mississippi, United States
🇺🇸
Advances In Health, Inc., Houston, Texas, United States

and more 157 locations

AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type Psoriasis

Phase 2

Completed

Conditions: Psoriasis

Interventions: Drug: AN2728 ointment, 2%
Drug: Ointment Vehicle

First Posted Date: 2011-02-21

Last Posted Date: 2017-04-17

Lead Sponsor: Pfizer

Target Recruit Count: 68

Registration Number: NCT01300052

Locations: 🇺🇸
Karl G. Heine, MD Dermatology, Henderson, Nevada, United States
🇺🇸
Academic Dermatology Associates, Albuquerque, New Mexico, United States
🇺🇸
J&S Studies, Inc., College Station, Texas, United States

and more 7 locations

A Trial To Assess The Safety, Tolerability, And Immunogenicity Of Rlp2086 Vaccine When Administered In Either 2- Or 3-Dose Regimens In Healthy Subjects Aged ≥11 To <19 Years

Phase 2

Completed

Conditions: Meningococcal Vaccine

Interventions: Biological: Vaccine

First Posted Date: 2011-02-18

Last Posted Date: 2022-10-27

Lead Sponsor: Pfizer

Target Recruit Count: 1714

Registration Number: NCT01299480

Locations: 🇵🇱
Krakowski Szpital Specjalistyczny, im. Jana Pawla II, Krakow, Poland
🇵🇱
Gabinet Lekarski, Debica, Poland
🇵🇱
Nzoz "Anamed" S.C, Lubartow, Poland

and more 43 locations

A Study To Assess The Duration Of Action Of PF-03526299 In Asthmatic Subjects Following Allergen Challenge

Phase 1

Withdrawn

Conditions: Asthma

Interventions: Drug: Active (PF-03526299)
Drug: Placebo

First Posted Date: 2011-02-18

Last Posted Date: 2011-12-02

Lead Sponsor: Pfizer

Registration Number: NCT01299467

A Study To Investigate The Safety And Toleration Of Multiple Oral Doses Of PF-03654764 In Combination With Fexofenadine In Healthy Subjects

Phase 1

Terminated

Conditions: Healthy

Interventions: Drug: PF-03654764 5mg plus fexofenadine 60mg
Drug: PF-03654764 2.5mg plus fexofenadine 60mg
Drug: placebo

First Posted Date: 2011-02-17

Last Posted Date: 2019-02-11

Lead Sponsor: Pfizer

Target Recruit Count: 36

Registration Number: NCT01298505

Locations: 🇸🇬
Pfizer Clinical Research Unit, Singapore, Singapore

A Study to Evaluate the NSAIDS Sparing Effect of Etanercept in Subjects With Axial Spondyloarthritis

Phase 4

Completed

Conditions: Axial Spondyloarthritis

Interventions: Drug: etanercept
Drug: placebo

First Posted Date: 2011-02-17

Last Posted Date: 2014-07-29

Lead Sponsor: Pfizer

Target Recruit Count: 90

Registration Number: NCT01298531

Locations: 🇫🇷
Institut Calot - Fondation Hopale, Berck-sur-Mer, France
🇫🇷
Hopital Pellegrin, Bordeaux Cedex, France
🇫🇷
Centre Hospitalier, Service de Rhumatologie, Cahors, France

and more 16 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy